 "Dr Reddy's to market Biocodex products in Romania")
Dr Reddy’s Laboratories has entered into a strategic alliance with the France-based Biocodex to market and distribute Biocodex products in the Romanian market. Biocodex has announced the change in partnership and has given Dr Reddy’s the complete rights for promotion and distribution of the Biocodex products across Romania, effective October 1, 2015, said Dr Reddy’s in a press release. Earlier, Akacia was in partnership with Biocodex for similar distribution pact.
With this new collaboration coming into existence, Dr Reddy’s will aim to develop the access of the Romanian patients to the prescription portfolio including Biocodex’s well-known OTC products Enterol and Otipax.
Enterol is the ethical pharmaceutical product composed of lyophilised Saccharomyces boulardii living cells in a concentration of 250 mg per capsule. Otipax is an ear drop solution containing phenazone and lidocaine hydrochloride, presented in bottles of 15 ml.
With this new collaboration coming into existence, Dr Reddy’s will aim to develop the access of the Romanian patients to the prescription portfolio including Biocodex’s well-known OTC products Enterol and Otipax.
Enterol is the ethical pharmaceutical product composed of lyophilised Saccharomyces boulardii living cells in a concentration of 250 mg per capsule. Otipax is an ear drop solution containing phenazone and lidocaine hydrochloride, presented in bottles of 15 ml.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%